The Enterprise Value as of November 2024 (TTM) for Mirati Therapeutics, Inc. (MRTX) is 3.91B

According to Mirati Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.91B. This represents a change of 73.06% compared to the average of 2.26B of the last 4 quarters.

Mirati Therapeutics, Inc. (MRTX) Historical Enterprise Value (quarterly & annually)

How has MRTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Mirati Therapeutics, Inc. over the last ten years is 2.48B. The current 3.91B Enterprise Value has changed 15.67% with respect to the historical average. Over the past ten years (40 quarters), MRTX's Enterprise Value was at its highest in in the December 2020 quarter at 9.32B. The Enterprise Value was at its lowest in in the December 2016 quarter at 37.93M.

Mirati Therapeutics, Inc. (MRTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mirati Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mirati Therapeutics, Inc. (MRTX) Average Enterprise Value

How has MRTX Enterprise Value performed in the past?

The current Enterprise Value of Mirati Therapeutics, Inc. (MRTX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Mirati Therapeutics, Inc. (MRTX) Enterprise Value vs. Peers

How is MRTX’s Enterprise Value compared to its peers?

Mirati Therapeutics, Inc.’s Enterprise Value is less than Reata Pharmaceuticals, Inc. (6.64B), less than Sarepta Therapeutics, Inc. (12.11B), less than Krystal Biotech, Inc. (5.10B), greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than Day One Biopharmaceuticals, Inc. (963.46M), greater than Amylyx Pharmaceuticals, Inc. (291.98M), greater than Terns Pharmaceuticals, Inc. (222.97M), greater than Apellis Pharmaceuticals, Inc. (3.90B), less than Madrigal Pharmaceuticals, Inc. (0), less than Viking Therapeutics, Inc. (7.46B), less than Hepion Pharmaceuticals, Inc. (5.81B), greater than PTC Therapeutics, Inc. (5.35M), greater than Akero Therapeutics, Inc. (3.21B), greater than null (2.00B),

Build a custom stock screener for Mirati Therapeutics, Inc. (MRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mirati Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mirati Therapeutics, Inc. (MRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mirati Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.